###begin article-title 0
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 775 780 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
We previously showed that mice lacking the high mobility group A1 gene (Hmga1-knockout mice) developed a type 2-like diabetic phenotype, in which cell-surface insulin receptors were dramatically reduced (below 10% of those in the controls) in the major targets of insulin action, and glucose intolerance was associated with increased peripheral insulin sensitivity. This particular phenotype supports the existence of compensatory mechanisms of insulin resistance that promote glucose uptake and disposal in peripheral tissues by either insulin-dependent or insulin-independent mechanisms. We explored the role of these mechanisms in the regulation of glucose homeostasis by studying the Hmga1-knockout mouse model. Also, the hypothesis that increased insulin sensitivity in Hmga1-deficient mice could be related to the deficit of an insulin resistance factor is discussed.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 876 882 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 147 152 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
We first show that HMGA1 is needed for basal and cAMP-induced retinol-binding protein 4 (RBP4) gene and protein expression in living cells of both human and mouse origin. Then, by employing the Hmga1-knockout mouse model, we provide evidence for the identification of a novel biochemical pathway involving HMGA1 and the RBP4, whose activation by the cAMP-signaling pathway may play an essential role for maintaining glucose metabolism homeostasis in vivo, in certain adverse metabolic conditions in which insulin action is precluded. In comparative studies of normal and mutant mice, glucagon administration caused a considerable upregulation of HMGA1 and RBP4 expression both at the mRNA and protein level in wild-type animals. Conversely, in Hmga1-knockout mice, basal and glucagon-mediated expression of RBP4 was severely attenuated and correlated inversely with increased Glut4 mRNA and protein abundance in skeletal muscle and fat, in which the activation state of the protein kinase Akt, an important downstream mediator of the metabolic effects of insulin on Glut4 translocation and carbohydrate metabolism, was simultaneously increased.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 292 298 <span type="species:ncbi:9606">humans</span>
These results indicate that HMGA1 is an important modulator of RBP4 gene expression in vivo. Further, they provide evidence for the identification of a novel biochemical pathway involving the cAMP-HMGA1-RBP4 system, whose activation may play a role in glucose homeostasis in both rodents and humans. Elucidating these mechanisms has importance for both fundamental biology and therapeutic implications.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1050 1051 1050 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1248 1249 1248 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1281 1286 1281 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1424 1425 1424 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 78 84 <span type="species:ncbi:9606">humans</span>
###xml 344 350 <span type="species:ncbi:9606">humans</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
Insulin resistance is a metabolic condition found relatively frequently among humans with chronic hyperinsulinemia and in experimental animal models with defective insulin signaling [1-3]. Recently, a link has been established between peripheral insulin sensitivity and the retinol (vitamin A) metabolism, and insulin resistance in rodents and humans has been linked to abnormalities of the vitamin A signaling pathway [4-6]. According to these studies, impaired glucose uptake in adipose tissue results in secondary systemic insulin resistance through release of the adipose-derived serum RBP4 [4,5]. However, it is unknown whether RBP4 effects on insulin sensitivity are vitamin A-dependent or vitamin A-independent. RBP4 (also called RBP) is mainly produced by the liver but also by adipocytes [7]. In plasma, retinol-RBP4 is found in an equimolar complex with transthyretin (TTR), which is a thyroid hormone transport protein that is synthesized in and secreted from the liver. This ternary complex prevents retinol-RBP4 excretion by the kidney [8]. By impairing insulin signaling in muscle, RBP4 inhibits glucose uptake and interferes with insulin-mediated suppression of glucose production in the liver, causing blood glucose levels to rise [4]. Conversely, mice lacking the RBP4 gene show increased insulin sensitivity, and normalizing increased RBP4 serum levels improves insulin resistance and glucose intolerance [4].
###end p 9
###begin p 10
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
HMGA1 is a small basic protein that binds to adenine-thymine (A-T) rich regions of DNA and functions mainly as a specific cofactor for gene activation [9]. HMGA1 by itself has no intrinsic transcriptional activity; rather, it can transactivate promoters through mechanisms that facilitate the assembly and stability of a multicomponent enhancer complex, the so-called enhanceosome, that drives gene transcription [9,10].
###end p 10
###begin p 11
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 629 631 629 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 632 635 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob </italic>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdk4 </italic>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1201 1208 1201 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1265 1270 1265 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1310 1315 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1389 1394 1389 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
###xml 1230 1236 <span type="species:ncbi:9606">humans</span>
###xml 1326 1330 <span type="species:ncbi:10090">mice</span>
As part of an investigation into the molecular basis regulating the human insulin receptor gene, we previously showed that HMGA1 is required for proper insulin receptor gene transcription [11,12]. More recently, we showed that loss of HMGA1 expression, induced in mice by disrupting the HMGA1 gene, caused a type 2-like diabetic phenotype, in which, however, impaired glucose tolerance and overt diabetes coexisted with a condition of peripheral insulin hypersensitivity [13]. Concomitant insulin resistance and insulin hypersensitivity in peripheral tissues may paradoxically coexist as observed in livers of lipodystrophic and ob/ob mice [14], as well as in Cdk4 knockout mice with defective pancreatic beta cell development and blunted insulin secretion [15]. The hypothesis that the paradoxical insulin hypersensitivity of Hmga1-deficient mice could be due to a deficit, in these animals, of RBP4 is supported by our data. Herein, by employing the Hmga1-knockout mouse model, we provide compelling evidence for the identification of a novel biochemical pathway involving HMGA1 and RBP4, whose activation by the cAMP pathway may play an important role in maintaining glucose metabolism homeostasis in vivo, in both rodents and humans. The importance of HMGA1 in RBP4 gene transcription was substantiated in Hmga1-deficient mice, in which loss of HMGA1 expression considerably decreased RBP4 mRNA abundance and RBP4 protein production.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
RBP4 gene transcription is induced by HMGA1 and cAMP
###end title 13
###begin p 14
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 534 539 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 858 863 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1016 1017 1016 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1156 1160 1156 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP </italic>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1384 1388 1384 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP </italic>
###xml 1482 1483 1482 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1486 1491 1486 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1665 1667 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1689 1690 1677 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1692 1697 1680 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1893 1898 1881 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 2084 2085 2072 2073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 2617 2618 2605 2606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 2756 2761 2744 2749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 2996 2999 2984 2987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP</italic>
###xml 3029 3030 3017 3018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 3256 3257 3244 3245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 3317 3322 3305 3310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 3386 3391 3374 3379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
###xml 2990 2995 <span type="species:ncbi:10090">mouse</span>
We first performed experiments to see whether HMGA1 had a role in activating the mouse RBP4 gene promoter at the transcriptional level. To test this possibility, HepG2 human hepatoma cells and mouse Hepa1 hepatoma cells were cotransfected transiently with mouse RBP4-Luc reporter plasmid plus increasing amounts of the HMGA1 expression vector. As shown in Figure 1, overexpression of HMGA1 considerably increased RBP4-Luc activity in both cell types and this effect occurred in a dose-dependent manner. Consistent with these results, RBP4 mRNA abundance was increased in cells overexpressing HMGA1 and was reduced in cells pretreated with siRNA targeting HMGA1 (Figure 1), indicating that activation of the RBP4 gene requires HMGA1. These data were substantiated by chromatin immunoprecipitation (ChIP) assay, showing that binding of HMGA1 to the endogenous RBP4 locus was increased in whole, intact HepG2 and Hepa1 cells naturally expressing HMGA1, and was decreased in cells exposed to siRNA against HMGA1 (Figure 1). Based on these results, in addition to previous observations indicating that cAMP, or agents which elevate intracellular cAMP, increase RBP transcript levels [16], we were interested to see whether a functional link could be established between cAMP, HMGA1, and RBP4. To this end, we first confirmed and extended the observation made by Jessen and Satre [16] that RBP is induced by cAMP in Hepa1 cells. As measured by Northern blot analysis of total RNA (Figure 2), RBP4 mRNA increased approximately 5-fold over the basal level in Hepa1 cells treated with 0.5 mM 8-bromo cAMP (Br-cAMP), a standard concentration for c-AMP induction experiments [16]. As shown in Figure 2, RBP4 mRNA levels increased starting at 3 h, peaking at 24 h and then declining, suggesting a transient transcriptional stimulation. To establish whether HMGA1 was required for basal and cAMP-dependent RBP4 transcription, we transfected the HMGA1 expression vector in Hepa1 cells treated or not with Br-cAMP and RBP4 protein levels were analyzed 48 h later by Western blot. As shown in Figure 2, RBP4 protein expression was enhanced in cells overexpressing HMGA1 and even further in cells treated with cAMP, in which an increase in HMGA1 protein expression was simultaneously observed, suggesting that induction of RBP4 by cAMP may occur, at least in part, through activation of endogenous HMGA1 expression. This hypothesis was supported by the fact that RBP4 was reduced in cAMP treated cells in which endogenous levels of HMGA1 were specifically lowered by transfecting cells with HMGA1 antisense expression plasmid (Figure 2). However, further experiments are needed to fully explain the role of cAMP on HMGA1 expression. The functional significance of HMGA1 in RBP4 gene expression was confirmed in transient transcription assays in Hepa1 (and differentiated 3T3-L1, data not shown) cells, in which overexpression of HMGA1 caused an increase in both basal and cAMP-induced Luc activity from the mouse RBP-Luc reporter plasmid (Figure 3). This effect was substantiated in HEK-293 cAMP-responsive cells, a cell line ideally suited for studying the effects of HMGA1 on transcription since it does not express appreciable levels of this protein. As shown in Figure 3, in support of the role that HMGA1 plays in the context of RBP4 gene, the direct effect of cAMP was less effective in promoting RBP4 transcription in HEK-293 cells expressing low levels of HMGA1, becoming considerably higher in cells with forced expression of HMGA1.
###end p 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>RBP4 </italic>gene expression is induced by HMGA1</bold>
###xml 42 48 42 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Top) </bold>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 176 182 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 410 414 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 512 521 508 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Middle) </bold>
###xml 521 527 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 649 655 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 723 728 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 849 858 845 854 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Bottom) </bold>
###xml 870 875 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 951 957 947 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 48 53 <span type="species:ncbi:10090">Mouse</span>
RBP4 gene expression is induced by HMGA1. (Top) Mouse RBP4-Luc reporter vector (2 mug) was transfected into HepG2 and Hepa1 cells plus increasing amounts (0, 0.5, or 1 mug) of HMGA1 expression plasmid. Data represent the means +/- standard errors for three separate experiments; values are expressed as factors by which induced activity increased above the level of Luc activity obtained in transfections with RBP4-Luc reporter vector plus the empty expression vector, which is assigned an arbitrary value of 1. (Middle) HMGA1 expression plasmid was transfected into HepG2 and Hepa1cells. After 6 h of transfection, the cells were treated with anti-HMGA1 (100 pmol), siRNA, or a non-targeting control siRNA, and endogenous RBP4 mRNA expression was measured 48 to 96 h later. Western blots of HMGA1 in each condition are shown in the autoradiograms. (Bottom) ChIP of the RBP4 promoter gene in HepG2 and Hepa1 cells, either untreated or pretreated with HMGA1 siRNA. ChIP was done using an anti-HMGA1 specific antibody (Ab).
###end p 15
###begin p 16
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stimulation of <italic>RBP4 </italic>mRNA and protein expression by cAMP and HMGA1</bold>
###xml 67 80 67 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Upper left) </bold>
###xml 261 266 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 277 281 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
###xml 336 349 335 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Lower left) </bold>
###xml 498 506 496 504 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Right) </bold>
###xml 594 600 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 626 627 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 643 645 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">as</italic>
Stimulation of RBP4 mRNA and protein expression by cAMP and HMGA1. (Upper left) 20 mug of total RNA from Hepa1 cells treated with the indicated concentrations of Br-cAMP for 24 h (lanes 1-7) were analysed by Northern blot. Hybridization was carried out with an RBP4 cDNA or an 18S RNA probe as a control of the RNA loaded on each lane. (Lower left) 20 mug of total RNA from Hepa1 cells treated with 0.5 mM Br-cAMP for the indicated times were loaded on each lane (lanes 1-8) and analysed as above. (Right) Hepa1 cells, in the absence or presence of an expression plasmid (1 mug) containing the HMGA1 cDNA in either the sense (s) or antisense (as) orientation, were left untreated or treated with Br-cAMP (0.5 mM), total protein extracts were prepared 48 h later and HMGA1 and RBP4 protein expression levels were detected by Western blot (WB) with anti-HMGA1 and anti-RBP4 antibodies, respectively. beta-actin, control of cellular protein loading. Densitometric analyses of three to five independent blots are shown.
###end p 16
###begin p 17
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of HMGA1 in basal and cAMP-induced RBP4 expression</bold>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rbp4</italic>
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 332 337 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 399 407 397 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
Role of HMGA1 in basal and cAMP-induced RBP4 expression. Rbp4-Luc reporter vector and HMGA1 expression plasmid (sense or antisense) were cotransfected into Hepa1 and HEK-293 cells, either untreated or treated with Br-cAMP. Data represent the means +/- standard errors for three separate experiments. Transcriptional activity of the RBP4 gene promoter is shown as the ratio of luciferase activity to Renilla activity (Luc/Ren) as described in the experimental procedures. Values are expressed as the factors by which induced activity increased above the level of Luc activity obtained in transfections with the reporter vector alone, which is assigned an arbitrary value of 1. Open bar, mock (no DNA); black bar, pGL3-basic (vector without an insert). Western blots of HMGA1 and beta-actin in each condition are shown in the autoradiograms.
###end p 17
###begin p 18
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
Thus, these data together demonstrate that HMGA1 is of major importance for transcriptional regulation of the RBP4 gene, and indicate that a functional link exists between cAMP, HMGA1, and RBP4.
###end p 18
###begin title 19
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Hmga1-deficient mice have reduced expression of RBP4 in liver and fat tissue and reduced serum RBP4 levels
###end title 19
###begin p 20
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 540 546 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
In the light of the above experimental results, indicating that HMGA1 plays a positive role in RBP4 gene transcription in living cultured cells, it was interesting to analyze the functional consequences of genetic ablation of HMGA1 on RBP4 in vivo, in Hmga1-knockout mice. To this end, we performed studies aimed at investigating the expression of RBP4 mRNA and protein in Hmga1-deficient mice and wild-type controls. As shown in Figure 4, RBP4 mRNA was severely attenuated in both liver and fat from Hmga1-null mice, and reduced by 50% in Hmga1 heterozygous mutants, as assessed by real-time quantitative polymerase chain reaction (qRT-PCR). Reduced RBP4 mRNA levels in liver and adipose tissue paralleled the decrease in RBP4 serum levels as detected by Western blot analysis of serum samples from age- and body weight-matched mice with diverse genotypes (Figure 4), thereby showing the requirement of HMGA1 for full RBP4 expression in whole animals.
###end p 20
###begin p 21
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 expression in wild-type and <italic>Hmga1</italic>-deficient mice</bold>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 462 464 461 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
RBP4 expression in wild-type and Hmga1-deficient mice. RBP4 mRNA in liver and fat from control and Hmga1-deficient mice, as measured by qRT-PCR (left), and densitometric quantification of RBP4 serum levels as detected by Western blot (WB) of serum samples (2 mul) from mice with diverse genotypes (right). In WB analysis, an anti-transthyretin (TTR) antibody was used to confirm similar amounts of protein on each lane. Results are from 4-6 mice in each group. *P < 0.01 versus control mice.
###end p 21
###begin title 22
###xml 62 66 <span type="species:ncbi:10090">mice</span>
HMGA1 and RBP4 expression increase in liver and fat of normal mice after intraperitoneal glucagon injection
###end title 22
###begin p 23
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 407 413 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 936 937 936 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 948 953 948 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 980 986 980 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1100 1106 1100 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 1110 1115 1110 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1296 1297 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1378 1383 1378 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1421 1426 1421 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1491 1496 1491 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1496 1499 1496 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1505 1510 1505 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1517 1522 1517 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1522 1525 1522 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1543 1544 1543 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1625 1630 1625 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1635 1642 1635 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1729 1735 1729 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 1739 1744 1739 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1812 1817 1812 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1962 1963 1962 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
###xml 1880 1884 <span type="species:ncbi:10090">mice</span>
Based on our observations in intact cultured cells, indicating a role for the cAMP signaling pathway in HMGA1 and RBP4 gene expression, cAMP-inducible transcriptional activation of the Hmga1 and RBP4 genes was investigated in vivo, in whole animals, by systemic administration of the intracellular cAMP-elevating hormone glucagon. Under these conditions, glucagon-stimulated cAMP responses in terms of both Hmga1 and RBP4 mRNA expression were first analyzed in wild-type control mice. Consistent with our data in Hepa1 cells, Hmga1 and RBP4 mRNA levels significantly increased in liver and fat of normal mice after intraperitoneal injection of glucagon (Figure 5). Time course analyses revealed that the induction and accumulation of Hmga1 mRNA preceded the expression of RBP4 mRNA in both tissues. In liver, RBP4 mRNA appeared after that for Hmga1, peaked after 6 h following glucagon injection, and then remained at a plateau (Figure 5). In fat, RBP4 mRNA appeared at 1 h after Hmga1 mRNA, peaked after 6 h of glucagon stimulation, and decreased smoothly thereafter (Figure 5). Increased levels of Hmga1 and RBP4 mRNAs were paralleled by the increase of Hmga1 and RBP4 protein expression, as measured by Western blot analysis of proteins from liver and fat of glucagon-injected animals (Figure 5). Interestingly, when similar experiments were carried out in glucagon injected Hmga1-deficient mice, tissue expression of RBP4 mRNA was severely attenuated in liver and fat from heterozygous (Hmga1+/-) and Hmga1-null (Hmga1-/-) animals (Figure 6), thereby indicating that HMGA1 is indeed required for maximal induction of the RBP4 gene in vivo, in the whole organism, and that the glucagon/adenylate cyclase system regulates both HMGA1 and RBP4 gene and protein expression. Consistent with this conclusion, liver RBP4 mRNA and protein expression levels were lower in fed wild-type mice, becoming higher during fasting, when circulating glucagon increases (Figure 6).
###end p 23
###begin p 24
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hmga1 </italic>and <italic>RBP4 </italic>mRNA and protein expression <italic>in vivo</italic>, in glucagon-injected wild-type mice</bold>
###xml 244 250 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS9 </italic>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methods</italic>
###xml 464 470 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 487 492 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 792 794 788 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
Hmga1 and RBP4 mRNA and protein expression in vivo, in glucagon-injected wild-type mice. Total RNA was isolated from liver (upper left) and fat (upper right) of 3-h-fasted mice, before and after intraperitoneal injection of glucagon. Levels of Hmga1 and RBP4 mRNA were measured at the indicated time intervals by qRT-PCR and normalized to RPS9 mRNA abundance, as described in Methods. Results are the mean values +/- s.e.m. from 4-6 animals per group. Black bars, Hmga1 mRNA; gray bars, RBP4 mRNA. Representative Western blots from liver (lower left) and fat (lower right) of mice before and after glucagon injection are shown. Densitometric analyses of immunoblots are shown in bar graphs as the mean +/- s.e.m. of data from 3-5 mice per each time point. Black bars, HMGA1; gray bars, RBP4.*P < 0.05 versus control mice (time 0).
###end p 24
###begin p 25
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 0 154 0 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of <italic>RBP4 </italic>mRNA levels in glucagon-injected wild-type and <italic>Hmga1</italic>-deficient mice, and liver RBP4 expression in wild-type mice during fasting and fed</bold>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS9 </italic>
###xml 446 451 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 451 454 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 456 458 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 474 479 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 479 482 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 484 486 482 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 503 508 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 508 511 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 513 515 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 521 523 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 676 681 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 869 871 867 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 946 951 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1092 1100 1090 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methods </italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
Comparison of RBP4 mRNA levels in glucagon-injected wild-type and Hmga1-deficient mice, and liver RBP4 expression in wild-type mice during fasting and fed. Total RNA was isolated from liver and fat of 3-h-fasted mice, before (time 0) and after 9 h of intraperitoneal injection of glucagon, and RBP4 mRNA was measured by qRT-PCR and normalized to RPS9 mRNA abundance. Results are the mean values +/- s.e.m. from 6-8 animals per group. Black bars, Hmga1+/+, n = 8; gray bars, Hmga1+/-, n = 6; white bars, Hmga1-/-, n = 6. *P < 0.05 versus each control (time 0). Western blots for HMGA1 protein expression are shown in liver and fat from all three genotypes (top). The levels of RBP4 mRNA and protein (shown at the bottom of the figure) were measured in liver of fed and 6-h-fasted wild-type mice (6 animals per group), using qRT-PCR and Western blot (WB), respectively. *P < 0.05 versus fed mice. Inset, cAMP was measured in liver from control and Hmga1-deficient mice, in both basal conditions and 3 h after the intraperitoneal injection of glucagon (1 mg/kg body weight), as described in the Methods section. The data are mean +/- s.e.m. for 4-6 animals per group.
###end p 25
###begin p 26
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 515 520 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 520 524 518 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 528 533 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 533 537 531 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 611 612 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
As a measure of the glucagon efficacy in glucagon-injected mice, a liver biopsy was taken before and after glucagon injection, and cAMP levels in liver were determined for both control and Hmga1-deficient mice (Figure 6, inset). No substantial difference was found in basal levels of cAMP (0.45 and 0.50 in Hmga1-/- and Hmga1+/-, respectively, versus 0.52 mumol/g tissue in controls). After glucagon injection, hepatic levels of cAMP increased to 1.50 mumol/g tissue in control mice, compared with 1.48 and 1.52 in Hmga1-/- and Hmga1+/- mice, respectively. Results similar to those shown in the inset of Figure 6 were also obtained in epididymal and subcutaneous fat pads from control and mutant animals (data not shown), thus indicating that the glucagon-stimulated cAMP synthesis did not differ among mice with diverse genotypes.
###end p 26
###begin title 27
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Hmga1-deficient mice have increased Glut4 expression and insulin signaling activity in skeletal muscle and fat
###end title 27
###begin p 28
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1054 1061 1054 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1462 1464 1462 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1519 1520 1519 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1612 1617 1612 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1806 1812 1806 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 1899 1905 1899 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 1919 1921 1919 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1959 1964 1959 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2009 2018 2009 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2104 2110 2104 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 2334 2336 2334 2336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2337 2339 2337 2339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2342 2347 2342 2347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2441 2446 2437 2442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2446 2450 2442 2446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 2454 2459 2450 2455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2459 2462 2455 2458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2478 2480 2474 2476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 1628 1632 <span type="species:ncbi:10090">mice</span>
###xml 1893 1898 <span type="species:ncbi:10090">mouse</span>
###xml 1975 1979 <span type="species:ncbi:10090">mice</span>
###xml 2357 2361 <span type="species:ncbi:10090">mice</span>
Systemic insulin resistance has been associated with elevation of serum RBP4, whereas genetic and pharmacological interventions aimed at decreasing serum RBP4 levels enhance insulin action and improve insulin sensitivity [4]. Increased peripheral insulin sensitivity during insulin-tolerance test was previously observed by us in Hmga1-knockout mice [13]. To verify whether a functional link indeed existed between HMGA1 and RBP4, and whether insulin hypersensitivity in Hmga1-deficient mice could be mediated by the HMGA1-RBP4 system, we carried out quantitative measurements of Glut4 mRNA transcript abundance. Examination by qRT-PCR showed a significant increase of Glut4 transcripts in both skeletal muscle and adipose tissues from Hmga1-deficient mice compared with controls (Figure 7). Accordingly, immunoblotting of muscle and fat tissue showed a 2- to 3-fold increase of Glut4 in the insulin hypersensitive Hmga1-knockout mice compared with controls (Figure 7), clearly indicating that an inverse correlation between RBP4 and Glut4 indeed exists in vivo, in this animal model of diabetes, in which reduced RBP4 may contribute to the maintenance of glucose homeostasis by increasing insulin signaling and peripheral insulin sensitivity. In agreement with this interpretation, the activation state of the protein kinase Akt, an important downstream target of PI 3-kinase regulating insulin serum effects on Glut4 translocation and carbohydrate metabolism [17], was increased in mutant animals. As shown in Figure 7, basal phospho-Akt immunoreactivity was higher in skeletal muscle and adipose tissues from Hmga1-deficient mice compared with wild-type controls, and this increase paralleled closely the increase of Glut4 protein in adipose and muscle plasma membranes from heterozygous and homozygous Hmga1 mutants. In line with previous observations on transcriptional repression of the mouse Glut4 gene by cAMP [18], endocrine upregulation of Glut4 in Hmga1-deficient mice was substantiated further by in vitro experiments (not shown), indicating that in isolated adipocytes treated with Br-cAMP, Glut4 mRNA was decreased in all three genotypes. A positive correlation of RBP4 levels with markers of lipid metabolism adversely affecting insulin sensitivity has been reported recently in both clinical and experimental studies [19,20]. Hmga1-knockout mice had lower levels of serum free fatty acids (0.45 +/- 0.13 and 0.34 +/- 0.07 in Hmga1+/+ and Hmga1-/-, respectively; P < 0.05), which might contribute to their improved insulin sensitivity.
###end p 28
###begin p 29
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 and pAkt expression in wild-type and <italic>Hmga1</italic>-deficient mice</bold>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 442 444 442 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 465 468 465 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 470 472 470 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 494 497 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
Glut4 and pAkt expression in wild-type and Hmga1-deficient mice. Glut4 mRNA (upper left) and protein content (lower left) in muscle and fat parallel pAkt protein abundance in skeletal muscle (upper right) and adipose tissue (lower right) from control and Hmga1-deficient mice. Representative Western blots of Glut4 and pAkt proteins are shown, together with the densitometric analyses of six to eight independent blots. Black bars, Hmga1+/+, n = 8; gray bars, Hmga1+/-, n = 6; white bars, Hmga1-/-, n = 6. *P < 0.05 versus Hmga1+/+.
###end p 29
###begin title 30
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Recombinant RBP4 injection reduces Glut4 and insulin signaling activity in muscle and fat tissue of Hmga1-deficient mice, and attenuates insulin hypersensitivity of these animals
###end title 30
###begin p 31
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 932 937 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 937 941 933 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 945 950 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 950 954 946 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1028 1033 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1033 1037 1025 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1041 1046 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1046 1050 1038 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
To demonstrate that increased insulin sensitivity in mutant mice was directly due to HMGA1 regulation of RBP4, we determined the effect of recombinant RBP4 administration on Akt phosphorylation and Glut4 protein expression in skeletal muscle from Hmga1-deficient mice. As shown in Figure 8, Akt phosphorylation was reduced in muscle from RBP4-injected mutant animals compared with saline-injected Hmga1 mutants. The reduction in Akt phosphorylation in these genotypes correlated inversely with RBP4 serum levels in the same animals (Figure 8) and paralleled the reduction of Glut4 in skeletal muscle and adipose (not shown) plasma membranes (Figure 8), indicating that, in these conditions, activation of the Akt-Glut4 pathway is regulated, at least in part, by circulating RBP4. Plasma insulin levels were slightly higher in RBP4-injected mice, but no significant difference was found (1.6 +/- 0.2 and 1.2 +/- 0.2 in RBP4-injected Hmga1+/- and Hmga1-/- respectively, versus 1.4 +/- 0.1 and 0.9 +/- 0.1 ng/ml in saline-injected Hmga1+/- and Hmga1-/- mice).
###end p 31
###begin p 32
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of recombinant RBP4 administration on Akt phosphorylation and Glut4 protein expression in <italic>Hmga1</italic>-deficient mice</bold>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 316 318 316 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 548 550 548 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 569 572 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
Effects of recombinant RBP4 administration on Akt phosphorylation and Glut4 protein expression in Hmga1-deficient mice. Basal (saline) levels of pAkt (left) and Glut4 (right) were increased in skeletal muscle of saline-injected Hmga1-deficient mice compared with controls, and were reduced following RBP4-injection (n = 6 per genotype). Densitometric quantifications of three independent experiments from 3 animals per genotype are shown, together with representative Western blots of pAkt, Glut4, and serum RBP4 of saline and RBP4-injected mice. *P < 0.05 versus Hmga1+/+.
###end p 32
###begin p 33
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 497 503 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 940 947 940 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 972 977 972 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1659 1664 1659 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1693 1698 1691 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1698 1702 1696 1700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1746 1751 1740 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1751 1755 1745 1749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1759 1764 1753 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1764 1768 1758 1762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1788 1790 1782 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 1630 1634 <span type="species:ncbi:10090">mice</span>
###xml 1675 1679 <span type="species:ncbi:10090">mice</span>
###xml 1702 1706 <span type="species:ncbi:10090">mice</span>
###xml 1768 1772 <span type="species:ncbi:10090">mice</span>
Consistent with the condition of insulin hypersensitivity, we previously reported that the glucose-lowering effect of exogenous insulin was enhanced in Hmga1-deficient mice during insulin-tolerance test (ITT) [13]. To support further the role of RBP4 in insulin hypersensitivity in Hmga1 mutants, we have determined the effect of RBP4 administration on the glucose fall induced by insulin in these genotypes during ITT. As shown in Figure 9, injection of human RBP4 in heterozygous and homozygous Hmga1 mutants caused a less dramatic fall in blood glucose levels, lessening the hypoglycemic response to intraperitoneal insulin observed in the saline-injected animals. Thus, taken together, our findings consistently support the role of HMGA1 as a key element in the transcriptional regulation of genes involved in glucose metabolism and add new insights into the compensatory mechanisms that may contribute to counteract insulin resistance in vivo. By directly regulating RBP4 gene transcription, HMGA1 enhances peripheral insulin sensitivity, ensuring glucose uptake in skeletal muscle. This, if on one hand might represent an adaptive mechanism to ameliorate insulin resistance in animals with a disadvantageous metabolic risk profile, on the other might indicate that the cAMP/HMGA1-mediated RBP4 expression during fasting (when glucagon peaks) may act physiologically to reduce insulin sensitivity in peripheral tissues, thereby contributing to the maintenance of euglycemia under this condition. This was supported by the observation that after an overnight fasting period (12-16 h) plasma glucose concentration in wild-type mice was higher than that of Hmga1-deficient mice (89 +/- 5 in Hmga1+/+ mice, versus 72 +/- 6 and 62 +/- 5 mg/dl in Hmga1+/- and Hmga1-/- mice, respectively; P < 0.05).
###end p 33
###begin p 34
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of RBP4 on insulin sensitivity</bold>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 451 454 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 642 648 642 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 658 660 658 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 719 722 719 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink"># P </italic>
###xml 750 755 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 755 759 755 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 776 779 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 381 386 <span type="species:ncbi:9606">Human</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
Effects of RBP4 on insulin sensitivity. Insulin-tolerance test (ITT) was assessed in Hmga1-deficient mice injected with saline alone (left), and in Hmga1 mutants injected chronically with purified RBP4 (right) (n = 6-8 per genotype in each condition). ITT was performed by measuring blood glucose levels in 12-h-fasted conscious mice injected intraperitoneally with human insulin (Human Actrapid, Novo Nordisk), 1 U/kg body weight. Open squares, Hmga1+/+; open circles, Hmga1+/-; open diamonds, Hmga1-/-. The degree of statistical significance was less in RBP4-injected Hmga1-deficient mice compared with the significance for saline-injected Hmga1 mutants. *P < 0.0001, saline-injected Hmga1-deficient mice versus Hmga1+/+; # P < 0.05, RBP4-injected Hmga1-/- mice versus Hmga1+/+.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1004 1009 1004 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1376 1383 1376 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1448 1450 1448 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1451 1453 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1700 1705 1700 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1722 1724 1722 1724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1898 1900 1895 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2002 2007 1996 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2104 2106 2098 2100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2266 2271 2260 2265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 2287 2289 2281 2283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 1019 1024 <span type="species:ncbi:10090">mouse</span>
###xml 1411 1416 <span type="species:ncbi:9606">human</span>
###xml 1417 1425 <span type="species:ncbi:9606">patients</span>
###xml 1716 1720 <span type="species:ncbi:10090">mice</span>
###xml 1813 1817 <span type="species:ncbi:10090">mice</span>
###xml 1929 1933 <span type="species:ncbi:10090">mice</span>
###xml 2281 2285 <span type="species:ncbi:10090">mice</span>
###xml 2527 2532 <span type="species:ncbi:10090">mouse</span>
We have previously shown that loss of HMGA1 protein expression, induced in mice by disrupting the HMGA1 gene, severely decreased insulin receptor expression (below 10% of control animals) and phosphorylation in the major targets of insulin action, largely impaired insulin signaling, and reduced insulin secretion, producing a type 2-like diabetic phenotype in which defects in both peripheral insulin sensitivity and pancreatic beta-cell insulin secretion were coexpressed simultaneously [13]. However, despite the severe decrease in insulin receptor signaling and insulin receptor production, the glucose-lowering effect of exogenous insulin was enhanced in Hmga1-deficient mice during ITT, and the glucose infusion rate necessary to maintain euglycemia was higher in mutant mice during hyperinsulinemic-euglycemic clamp [13], supporting the existence of alternative pathways of insulin signaling promoting glucose uptake and disposal in certain adverse metabolic conditions such as those found in the Hmga1-knockout mouse. The existence of signaling pathways promoting glucose uptake and utilization in peripheral tissues through mechanisms that are independent of insulin has been postulated before, on the basis of experimental observations supporting the existence of molecular circuits/pathways that can compensate for the decrease in insulin-stimulated glucose uptake in vivo, in both animal models and human patients with type 2 diabetes [21-23]. However, how these compensatory mechanisms are activated has remained hitherto largely undefined. As previously shown, consistent with the ubiquitous distribution of HMGA1, insulin receptor expression was also reduced in pancreatic tissue from Hmga1-deficient mice [13]. Loss of insulin secretion in response to glucose has been reported in IRbeta knockout mice with tissue-specific knockout of the insulin receptor in pancreatic beta cells [24]. As in the IRbeta knockout mice, plasma insulin after glucose challenge was considerably reduced in Hmga1-mutant animals, in which the acute first-phase insulin secretory response was severely blunted [13], indicating a glucose-induced insulin secretory defect. In addition, substantial abnormalities in pancreatic islet morphology and size have been described in Hmga1-knockout mice [13], indicating that decreased insulin secretion in this genotype may also depend on reduced beta-cell mass. Thus, defects in both pancreatic beta-cell insulin secretion and peripheral insulin action coexist simultaneously in this knockout mouse model of diabetes, in which activation of compensatory mechanisms to efficiently overcome these metabolic abnormalities may be of vital importance.
###end p 36
###begin p 37
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1174 1179 1174 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1494 1499 1494 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1647 1652 1647 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1912 1917 1912 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 2084 2089 2084 2089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 2194 2199 2194 2199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 243 249 <span type="species:ncbi:9606">humans</span>
###xml 517 523 <span type="species:ncbi:9606">humans</span>
###xml 762 768 <span type="species:ncbi:9606">humans</span>
###xml 909 915 <span type="species:ncbi:9606">humans</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1090 1096 <span type="species:ncbi:9606">humans</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
###xml 1509 1514 <span type="species:ncbi:10090">mouse</span>
###xml 1663 1667 <span type="species:ncbi:10090">mice</span>
###xml 1716 1721 <span type="species:ncbi:9606">human</span>
###xml 1734 1739 <span type="species:ncbi:10090">mouse</span>
Downregulation of Glut4 in adipose tissue is a typical feature of insulin-resistant states, such as obesity and type 2 diabetes [25]. It has been found that the decrease in Glut4 expression that occurs in the fatty tissue of obese animals and humans is accompanied by increased expression and secretion of the adipocyte-derived RBP4 fraction [4,5], suggesting that RBP4 production is tightly regulated by adipose tissue glucose uptake. RBP4 has been recently implicated in systemic insulin sensitivity in rodents and humans, in which elevated serum RBP4 levels were associated with reduced expression of Glut4 in adipocytes, and correlated inversely with peripheral insulin sensitivity. However, based on current data, the role of RBP4 in insulin sensitivity in humans is still controversial and might be restricted to rodent models only. Interspecies differences are known to exist and discrepancies between humans and mice might emphasize the role of non-genetic environmental factors and genetic modifiers in determining the phenotypic variations in RBP4 and insulin sensitivity between humans and animal models. Our results in the present study clearly indicate that in Hmga1-knockout mice RBP4 levels are considerably decreased in serum and in whole liver and adipose tissue extracts, strictly linking HMGA1 and RBP4 expression. We propose that HMGA1 deficiency adversely affects RBP4 expression and this, in animals with a disadvantageous metabolic risk profile like that observed in the Hmga1-knockout mouse model, might reflect an adaptive mechanism to increase glucose uptake and glucose disposal. Consistent with the results obtained in Hmga1-deficient mice, RBP4 was considerably reduced in cells of both human (HepG2) and mouse (Hepa1) origin readily expressing RBP4, following perturbation of endogenous HMGA1 protein expression in cells treated with siRNA against HMGA1. Conversely, an increase in RBP4 mRNA abundance was observed in both cell lines following forced expression of HMGA1, consistently supporting a role for HMGA1 in the transcriptional activation of the RBP4 gene. These findings were substantiated further by ChIP analysis, showing that HMGA1 indeed binds to the RBP4 locus in intact living cells.
###end p 37
###begin p 38
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Signal transduction pathways which raise intracellular cAMP have been reported to have a potential role in the regulation of RBP4 gene expression [16]. Although the molecular mechanisms underlying this effect remain poorly understood, evidence exists supporting the notion that the regulation of RBP4 gene transcription via the cAMP signaling pathway may be physiologically relevant. One important physiological condition in which intracellular cAMP increases is in response to low glucose availability. In this metabolic setting, a concomitant predominance of circulating counter-regulatory hormones, in particular pancreatic glucagon acting via the cAMP pathway, induces glycogenolysis and gluconeogenesis in the liver, which produce and release hepatic glucose in the blood. In this regard, the cAMP-element-binding protein (CREB) has been identified as a critical transcriptional checkpoint which, in response to cAMP, promotes hepatic glucose output through the synergistic activation of distinct transcriptional effector pathways, which include the PPAR gamma coactivator 1 (PGC1) and the NR4A orphan nuclear receptors [26].
###end p 38
###begin p 39
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4</italic>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 921 926 921 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1300 1305 1300 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 1370 1372 1370 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1373 1375 1373 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1496 1497 1496 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1656 1661 1656 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1764 1771 1764 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
###xml 1488 1494 <span type="species:ncbi:9606">humans</span>
###xml 1633 1639 <span type="species:ncbi:9606">humans</span>
###xml 1672 1676 <span type="species:ncbi:10090">mice</span>
###xml 1937 1941 <span type="species:ncbi:10090">mice</span>
In this paper, we report that systemic injection of glucagon to wild-type control mice caused an increase in RBP4 mRNA and protein expression, along with an increase of both intracellular cAMP and HMGA1 levels. Glucagon effects were attenuated in Hmga1-deficient mice, supporting a distinct role for HMGA1 in the regulation of RBP4 gene expression and functionally linking this two genes. As a consequence of the functional link between HMGA1 and RBP4, a significant increase in Glut4 mRNA and protein was observed in both skeletal muscle and adipose tissues from Hmga1-deficient mice compared with controls. An inverse relationship between RBP4 and Glut4 has been described previously, in the adipose-Glut4-/- mouse, in which the decrease in Glut4 expression that occurs in the fatty tissue of this mutant genotype is accompanied by increased expression and secretion of the fat-derived RBP4 [4]. In our model, instead, RBP4 expression is genetically impaired due to the lack of HMGA1 and Glut4 is increased in both muscle and fat, suggesting that abnormalities in RBP4 and/or metabolites of the vitamin A metabolism may directly affect whole-body insulin action and peripheral insulin sensitivity. In support of this possibility, identification of regulatory single nucleotide polymorphisms in the RBP4 gene associated with type 2 diabetes has been recently reported [27,28], while correlations of RBP4 with insulin resistance have been confirmed in experimental clinical approaches in humans [7]. Although conflicting results have been reported, raising doubt about the postulated relationship of RBP4 with insulin sensitivity in humans, our results in Hmga1-deficient mice confirm that an inverse correlation indeed exists between RBP4 and insulin sensitivity in vivo, in this animal model of diabetes, lending support to previous hypotheses that lowering RBP4 levels would be helpful in ameliorating insulin resistance, at least in mice.
###end p 39
###begin p 40
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
Overall, our findings provide mechanistic insight into the regulation of glucose uptake and disposal in peripheral tissues, and support further the role of HMGA1 as a molecule that is likely to be an important emerging factor in the transcriptional activity of genes implicated in the maintenance of glucose homeostasis and metabolic control, such as the insulin receptor gene [11-13], the leptin gene [29], and, as shown here, the RBP4 gene. Apart from the intrinsic biological interest in elucidating the mechanisms leading to improvement in insulin sensitivity, a clear understanding of the molecular process involved is of potential importance in the development of new therapeutic strategies for patients with metabolic disorders such as obesity, diabetes, and other insulin resistant states.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We propose that HMGA1 can serve as a modulator of both RBP4 gene expression and protein function and represents an important novel mediator of glucose homeostasis in vivo.
###end p 42
###begin title 43
Methods
###end title 43
###begin title 44
Plasmids, transfections, and ChIP
###end title 44
###begin p 45
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XhoI </italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 934 940 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1022 1028 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1214 1220 1214 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1360 1365 1360 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
The RBP4-Luc reporter plasmid was obtained by cloning the NheI/XhoI 1427-bp sequence of the mouse RBP4 promoter (-1417 to +10) into pGL3 (Promega). This fragment was amplified from genomic DNA using the following modified primers: 5'-TTGCTAGCATGGCTAAGGTGCTTGTTGAAA-3', 5'-TTCTCGAGCACACCCACTCCATCTCACC-3' and the integrity of this construct was checked by DNA sequencing. RBP4-Luc reporter plasmid, together with either the control vector plasmid or expression plasmid encoding HMGA1 [11], was transiently transfected into cultured cells using LipofectAMINE 2000 reagent (Invitrogen), and Luc activity was assayed 48 h later, as previously described [30]. Renilla control vector served as an internal control of transfection efficiency, together with measurements of protein expression levels. For antisense HMGA1 experiments, RBP4-containing vector was cotransfected into Hepa1 cells with the expression plasmid pcDNA1 containing the HMGA1 cDNA in the antisense orientation [12]. Small interfering RNA (siRNA) targeted to HMGA1 [30] was transfected into cells at 50% to 60% confluency and cells were analyzed 48 to 96 h later. ChIP assay was performed in HepG2 and Hepa1 cells, either untreated or pretreated with HMGA1 siRNA as described previously [31]. Formaldehyde-fixed DNA-protein complex was immunoprecipitated with anti-HMGA1 antibody. Primers for the RBP4 sequence were used for PCR amplification of immunoprecipitated DNA (30 cycles), using PCR ready-to-go beads (Amersham Pharmacia Biotech). PCR products were electrophoretically resolved on 1.5% agarose gel and visualized by ethidium bromide staining.
###end p 45
###begin title 46
Animals
###end title 46
###begin p 47
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
Male Hmga1-deficient and wild-type mice aged 6-9 months were studied. The generation of these animals and many of the physiological characteristics of the mice have been described in detail [13]. All animal work was carried out at the Animal Facility at the 'Istituto dei Tumori di Napoli', and at the Faculty of Pharmacy, Roccelletta di Borgia, Catanzaro, using approved animal protocols and in accordance with institutional guidelines. Serum free fatty acid levels were measured in wild-type and Hmga1-knockout mice (n = 12-16 per genotype) using the NEFA C kit (Wako).
###end p 47
###begin title 48
Real-time PCR and Western blot
###end title 48
###begin p 49
###xml 328 334 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGA1 </italic>
###xml 406 411 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 483 489 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 564 569 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS9 </italic>
###xml 1359 1364 1331 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS9 </italic>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
For qRT-PCR, total cellular RNA was extracted from tissues using the RNAqueous-4PCR kit and subjected to DNase treatment (Ambion). RNA levels were normalized against 18S ribosomal RNA in each sample, and cDNAs were synthesized from 2 mug of total RNA using the RETROscript first strand synthesis kit (Ambion). Primers for mouse HMGA1 (NM_016660.2) (5'-GCAGGAAAAGGATGGGACTG-3'; 5'-AGCAGGGCTTCCAGTCCCAG-3'), RBP4 (NM_011255.2) (5'-AGGAGAACTTCGACAAGGCT-3'; 5'-TTCCCAGTTGCTCAGAAGAC-3'), Glut4 (NM_009204) (5'-TCATTGTCGGCATGGGTTT-3'; 5'-CGGCAAATAGAAGGAAGACGTA-3'), and RPS9 (NM_029767.2) (5'-CTGGACGAGGGCAAGATGAAGC-3'; 5'-TGACGTTGGCGGATGAGCACA-3') were designed according to sequences from the GenBank database. A real-time thermocycler (Eppendorf Mastercycler ep realplex ES) was used to perform quantitative PCR. In a 20-mul final volume, 0.5 mul of the cDNA solution was mixed with SYBR Green RealMasterMix (Eppendorf), and 0.3 muM each of sense and antisense primers. The mixture was used as a template for the amplification by the following protocol: a denaturing step at 95degreesC for 2 min, then an amplification and quantification program repeated for 45 cycles of 95degreesC for 15 s, 55degreesC for 25 s, and 68degreesC for 25 s, followed by the melting curve step. SYBR Green fluorescence was measured, and relative quantification was made against the RPS9 cDNA used as an internal standard. All PCR reactions were done in triplicate.
###end p 49
###begin p 50
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 443 449 <span type="species:ncbi:9986">rabbit</span>
###xml 549 553 <span type="species:ncbi:9925">goat</span>
###xml 611 617 <span type="species:ncbi:9986">Rabbit</span>
Western blot analysis was performed to analyze HMGA1 and RBP4 protein expression in whole-cell liver and fat extracts from normal and mutant mice, using polyclonal specific antibodies raised against HMGA1 [11] and RBP4 (AdipoGen, Inc.). For the measurement of serum RBP4, blood was collected from the retro-orbital sinus, plasma protein extracts were resolved on 12% SDS-PAGE, blotted onto nitrocellulose membranes and RBP4 was detected using rabbit polyclonal antisera at 1:2000 dilution, as suggested by the manufacturer. TTR was detected using a goat anti-TTR polyclonal antibody (Santa Cruz Biotechnology). Rabbit anti-Glut4 polyclonal antibody was used as previously described [13].
###end p 50
###begin title 51
In vivo studies with the peptide hormone glucagon
###end title 51
###begin p 52
###xml 335 337 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
For systemic administration of exogenous glucagon, mice were injected in the peritoneal cavity with human glucagon (1 mg/kg body weight) or saline after 3 h of fasting. At this dose, the peak increase of plasma glucagon in all genotypes was ~96% +/- 10% above pre-injection levels, reflecting similar previous observations in rodents [32]. At different times after the injection the mice were killed by cervical dislocation, the liver and fat were rapidly removed, frozen into liquid nitrogen and stored at -80degreesC until processed. For cAMP determination, frozen samples were first homogenized in ice-cold trichloroacetic acid (TCA) (6% wt/vol), and cAMP was determined using the cAMP enzyme immunoassay kit (Amersham Pharmacia Biotech), according to the instructions specified by the manufacturer.
###end p 52
###begin title 53
RBP4 purification and injection
###end title 53
###begin p 54
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4 </italic>
###xml 237 254 237 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 237 253 <span type="species:ncbi:562">Escherichia coli</span>
Human RBP4 cDNA cloned into a pET3a expression vector was a kind gift from JW Kelly (The Scripps Research Institute). Based on previously published methodology [33], RBP4 protein expression vector was transformed into the BL21 strain of Escherichia coli (Stratagene), expanded in suspension culture and induced for 6 h with 1 mM isopropyl-D-thiogalactopyranoside to stimulate protein expression. Bacteria were pelleted and lysed by osmotic shock [34]. From this point on, all steps, including denaturation, refolding, and RBP4 purification, were performed essentially as described elsewhere [35]. Protein fractions were examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, and desired fractions were pooled together, concentrated with an Amicon Centriprep-10 concentrator (Millipore), and stored at -80degreesC.
###end p 54
###begin p 55
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1 </italic>
###xml 398 399 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
To determine whether elevation of RBP4 affected insulin hypersensitivity in vivo, in Hmga1-deficient mice, heterozygous and homozygous Hmga1 mutants, were intraperitoneally injected twice daily (at 12-h intervals) with 200 mug of purified human RBP4 (13 mug/g body weight per mouse) for 7 days. This resulted in a daily average serum level of human RBP4 similar to that of control mice (see Figure 8), which received physiological saline solution according to the same schedule above.
###end p 55
###begin title 56
Statistical analysis
###end title 56
###begin p 57
###xml 98 100 98 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
The ANOVA test was used to evaluate the differences between the groups of mice. For all analyses, P < 0.05 was considered significant.
###end p 57
###begin title 58
Abbreviations
###end title 58
###begin p 59
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
Akt: protein kinase B; Br-cAMP: 8-bromo cAMP; cAMP: cyclic adenosine monophosphate; CREB: cAMP-element-binding protein; Glut4: glucose transporter-4; HEK-293: human embryonic kidney-293; Hepa1: mouse hepatoma; HMGA1: high mobility group A1; ITT: insulin-tolerance test; PGC1: PPAR gamma coactivator 1; qRT-PCR: quantitative Real-Time PCR; RBP4: retinol-binding protein 4; siRNA: small interfering RNA; TCA: trichloroacetic acid; TTR: transthyretin.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
###xml 392 400 392 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
EC and FP performed qRT-PCR studies as well as transient transfections with reporter and expression vectors, and participated in the design of the study. SI was involved in Western blotting studies and assisted FP in performing transfections with siRNA. ILP participated in Western blotting and performed cloning studies. DP, EG, GDS and AF participated in the analysis and discussion of the in vivo data from normal and mutant mice. GB, AL, and VC performed certain aspects of the assays detailed in Figures 1, 2 and 3 and contributed with Northern blotting studies. DF provided helpful discussion on this manuscript and participated in ChIP analysis. AB conceived, coordinated, and supervised the project, analyzed data, and wrote the manuscript. All authors read and approved the final manuscript.
###end p 61
###begin title 62
Acknowledgements
###end title 62
###begin p 63
We remain extraordinarily indebted to Drs R Citraro and N Costa and the entire staff of the animal facilities for animal care. We are most grateful to Dr JW Kelly for his generous gift of RBP4 expression vector, pET3a. We would also like to thank Mrs A Malta and Dr G Ceravolo for secretarial help. This work was supported by Telethon-Italy, grant GGP04245, and MIUR, protocol 2004062059-002 Italy (AB).
###end p 63
###begin article-title 64
Insulin action, diabetogenes, and the cause of type II diabetes (Banting Lecture)
###end article-title 64
###begin article-title 65
Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance
###end article-title 65
###begin article-title 66
Insulin resistance or insulin deficiency: which is the primary cause of NIDDM?
###end article-title 66
###begin article-title 67
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
###end article-title 67
###begin article-title 68
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
###end article-title 68
###begin article-title 69
Retinaldehyde represses adipogenesis and diet-induced obesity
###end article-title 69
###begin article-title 70
Retinol-binding protein-4 in experimental and clinical metabolic disease
###end article-title 70
###begin article-title 71
Structure of a complex of two plasma proteins: transthyretin and retinol binding protein
###end article-title 71
###begin article-title 72
High-mobility group proteins: architectural components that facilitate chromatin function
###end article-title 72
###begin article-title 73
###xml 19 24 <span type="species:ncbi:9606">human</span>
Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
###end article-title 73
###begin article-title 74
###xml 30 35 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y)
###end article-title 74
###begin article-title 75
###xml 72 77 <span type="species:ncbi:9606">human</span>
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription
###end article-title 75
###begin article-title 76
###xml 81 87 <span type="species:ncbi:9606">humans</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
###end article-title 76
###begin article-title 77
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
###end article-title 77
###begin article-title 78
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia
###end article-title 78
###begin article-title 79
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Induction of mouse retinol binding protein gene expression by cyclic AMP in Hepa 1-6 cells
###end article-title 79
###begin article-title 80
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)
###end article-title 80
###begin article-title 81
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Transcriptional repression of the mouse insulin-responsive glucose transporter (GLUT4) gene by cAMP
###end article-title 81
###begin article-title 82
###xml 119 122 <span type="species:ncbi:9606">men</span>
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease
###end article-title 82
###begin article-title 83
###xml 152 158 <span type="species:ncbi:9606">humans</span>
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans
###end article-title 83
###begin article-title 84
Insulin signaling pathways in time and space
###end article-title 84
###begin article-title 85
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Insulin receptor knockout mice
###end article-title 85
###begin article-title 86
The cellular fate of glucose and its relevance in type 2 diabetes
###end article-title 86
###begin article-title 87
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
###end article-title 87
###begin article-title 88
Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus
###end article-title 88
###begin article-title 89
Transcriptional regulation of metabolism
###end article-title 89
###begin article-title 90
Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia
###end article-title 90
###begin article-title 91
Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits
###end article-title 91
###begin article-title 92
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation
###end article-title 92
###begin article-title 93
###xml 89 94 <span type="species:ncbi:9606">human</span>
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer
###end article-title 93
###begin article-title 94
The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione-PPARg agonists
###end article-title 94
###begin article-title 95
###xml 102 105 <span type="species:ncbi:10116">rat</span>
Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of matabolic syndrome X
###end article-title 95
###begin article-title 96
###xml 12 17 <span type="species:ncbi:9606">human</span>
Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization
###end article-title 96
###begin article-title 97
A rapid and efficient purification method for recombinant annexin V for biophysical studies
###end article-title 97
###begin article-title 98
RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome
###end article-title 98

